<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2008-6-543-550</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-265</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>СОСТОЯНИЕ ИММУННОГО СТАТУСА И АКТИВНОСТЬ ФЕРМЕНТОВ В ЛИМФОЦИТАХ КРОВИ У БОЛЬНЫХ НА РАЗНЫХ СТАДИЯХ ОСТРОГО ЛИМФОБЛАСТНОГО ЛЕЙКОЗА</article-title><trans-title-group xml:lang="en"><trans-title>IMMUNE PROFILE AND ENZYMES ACTIVITY STATE IN BLOOD LYMPHOCYTES IN PATIENTS OF DIFFERENT STAGES ACUTE LYMPHOBLAST LEUKEMIA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>660022, г. Красноярск, ул. Партизана Железняка, 3г</p></bio><email xlink:type="simple">ovsmirnova71@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манчук</surname><given-names>В. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Manchouk</surname><given-names>V. T.</given-names></name></name-alternatives><email xlink:type="simple">ovsmirnova71@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савченко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savchenko</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">ovsmirnova71@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГУ НИИ Медицинских проблем Севера СО РАМН, г. Красноярск</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>18</day><month>07</month><year>2014</year></pub-date><volume>10</volume><issue>6</issue><fpage>543</fpage><lpage>550</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смирнова О.В., Манчук В.Т., Савченко А.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Смирнова О.В., Манчук В.Т., Савченко А.А.</copyright-holder><copyright-holder xml:lang="en">Smirnova O.V., Manchouk V.T., Savchenko A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/265">https://www.mimmun.ru/mimmun/article/view/265</self-uri><abstract><p>Резюме. Исследовано состояния иммунного статуса и активности ферментов в лимфоцитах крови у больных на разных стадиях острого лимфобластного лейкоза. Установлено, что у всех больных иммунный статус характеризовался снижением содержания Т-лимфоцитов. На стадии первичной атаки снижено содержание CD4+ клеток, повышена концентрация IgM и IgG. При ремиссии обнаружены наиболее низкие величины исследуемых параметров. Характерными особенностями рецидива являлись высокое содержание NK-клеток и дисбаланс уровней концентрации основных классов иммуноглобулинов. При исследовании метаболизма лимфоцитов у больных обнаружено, что при первичной атаке и рецидиве снижена интенсивность анаэробного окисления глюкозы и уровень реакций макромолекулярного синтеза. У больных на стадии ремиссии данные процессы восстанавливались до диапазона нормы. На всех стадиях в лимфоцитах крови выявляется снижение активности глутатионредуктазы.</p></abstract><trans-abstract xml:lang="en"><p>Abstract. We studied immunological state and activity of enzymes in blood lymphocytes from the patients at different stages of acute lymphoblastic leukemia. We have revealed that immune state in all the patients was characterized by decreased contents of T-lymphocytes. Upon first attack of the disease, they showed a decrease in CD4+cells, as well as increased concentration of IgM and IgG. During remission, we have found the lowest values of all the parameters under study. In relapsing patients, high content of NK-cells, and imbalance between the main Ig classes were noted. When studying metabolism of lymphocyte, it was revealed that, in first attack and relapse phase, both intensity of anaerobic glucose oxidation, and levels of macromolecular synthetic reactions were decreased. In remission, all these processes did recover to normal range. At all stages of disease, glutathione reductase activity was found to be decreased in blood lymphocytes. (Med. Immunol., vol. 10, N 6, pp 543-550).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>иммунитет</kwd><kwd>острый лимфобластный лейкоз</kwd><kwd>ферменты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>immunity</kwd><kwd>acute lymphoblastic leukemia</kwd><kwd>enzymes activity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Березов Т.Т., Коровкин Б.Ф. Биологическая химия. – М.: Медицина, 1998. – 704 c.</mixed-citation><mixed-citation xml:lang="en">Березов Т.Т., Коровкин Б.Ф. Биологическая химия. – М.: Медицина, 1998. – 704 c.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Волкова М.А. Клиническая онкогематология. – М.: Медицина, 2001. – 576 с.</mixed-citation><mixed-citation xml:lang="en">Волкова М.А. Клиническая онкогематология. – М.: Медицина, 2001. – 576 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьев А.И. Руководство по гематологии в 3-х томах. – М.: Ньюдиамед, 2002.</mixed-citation><mixed-citation xml:lang="en">Воробьев А.И. Руководство по гематологии в 3-х томах. – М.: Ньюдиамед, 2002.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева Е.Е., Афанасьев Б.В., Тотолян А.А. Иммунофенотипирование в диагностике острого лейкоза (лекция) //Клиническая лаб. диагностика. – 2004. – № 7. – С. 25-32.</mixed-citation><mixed-citation xml:lang="en">Зуева Е.Е., Афанасьев Б.В., Тотолян А.А. Иммунофенотипирование в диагностике острого лейкоза (лекция) //Клиническая лаб. диагностика. – 2004. – № 7. – С. 25-32.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Земсков А.М., Караулов А.В., Земсков В.М. Комбинированная иммунокоррекция. – М.: Наука, 1994. – 260 с.</mixed-citation><mixed-citation xml:lang="en">Земсков А.М., Караулов А.В., Земсков В.М. Комбинированная иммунокоррекция. – М.: Наука, 1994. – 260 с.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Савченко А.А., Сунцова Л.Н. Высокочувствительное определение активности дегидрогеназ в лимфоцитах периферической крови биолюминесцентным методом // Лаб. дело. – 1989. – № 11. – С. 23-25.</mixed-citation><mixed-citation xml:lang="en">Савченко А.А., Сунцова Л.Н. Высокочувствительное определение активности дегидрогеназ в лимфоцитах периферической крови биолюминесцентным методом // Лаб. дело. – 1989. – № 11. – С. 23-25.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chiou S.H., Sheu B.C., Chang W.C., Wang X., Zheng J., Liu J., Yao J., He Y., Li X., Yu J. Current concepts of tumor-infiltrating lymphocytes in human malignancies // J. Reprod. Immunol. – 2005. – Vol. 67, N 1-2. – P. 35-50.</mixed-citation><mixed-citation xml:lang="en">Chiou S.H., Sheu B.C., Chang W.C., Wang X., Zheng J., Liu J., Yao J., He Y., Li X., Yu J. Current concepts of tumor-infiltrating lymphocytes in human malignancies // J. Reprod. Immunol. – 2005. – Vol. 67, N 1-2. – P. 35-50.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hashimoto S., Ishisaki A., Yamato K. Intracellular apoptosis-inducing factor is induced by a vacuolar type H+-ATPase inhibitor in B lineage cells //J. Cell Physiol. – 2001. – Vol. 186, N 1. – P. 65-72.</mixed-citation><mixed-citation xml:lang="en">Hashimoto S., Ishisaki A., Yamato K. Intracellular apoptosis-inducing factor is induced by a vacuolar type H+-ATPase inhibitor in B lineage cells //J. Cell Physiol. – 2001. – Vol. 186, N 1. – P. 65-72.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mazur B., Olejnik I., Wylezol I., Sonta-Jakimczyk D., Szczepanski T., Karpe J. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia // Pediatr. Hematol. Oncol. – 2003. – Vol. 20, N 4. – P. 303-308.</mixed-citation><mixed-citation xml:lang="en">Mazur B., Olejnik I., Wylezol I., Sonta-Jakimczyk D., Szczepanski T., Karpe J. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia // Pediatr. Hematol. Oncol. – 2003. – Vol. 20, N 4. – P. 303-308.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nakamura H., Idiris A., Kato Y., Kato H. An increase in the percentage of HLA-DR-positive peripheral leukocytes predicts a poor prognosis in patients with squamous cell carcinoma of the lung //Oncol. Rep. – 2004. – Vol. 11, N 3. – P. 673-676.</mixed-citation><mixed-citation xml:lang="en">Nakamura H., Idiris A., Kato Y., Kato H. An increase in the percentage of HLA-DR-positive peripheral leukocytes predicts a poor prognosis in patients with squamous cell carcinoma of the lung //Oncol. Rep. – 2004. – Vol. 11, N 3. – P. 673-676.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Peshikova M.V., Dolgushin I.I., Rusanova N.N. Etiology and structure of infectious complications of cytostatic therapy in children with acute lymphoblastic leukemia and non-B-cell non-Hodgkin lymphomas // Zh. Mikrobiol. Epidemiol. Immunobiol. – 2002. – N 1. – P. 70-71.</mixed-citation><mixed-citation xml:lang="en">Peshikova M.V., Dolgushin I.I., Rusanova N.N. Etiology and structure of infectious complications of cytostatic therapy in children with acute lymphoblastic leukemia and non-B-cell non-Hodgkin lymphomas // Zh. Mikrobiol. Epidemiol. Immunobiol. – 2002. – N 1. – P. 70-71.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
